Teladoc Health, INC Schedule 13G passive stakes

Vanguard Capital Management has reported beneficial ownership of 9,205,306 shares, representing 5.16% of Teladoc Health's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 6.97% in Teladoc Health Inc. common stock as of March 31, 2026.

The Vanguard Group has amended its Schedule 13G for Teladoc Health Inc., reporting 0% beneficial ownership following an internal corporate realignment.

Point72 Asset Management, along with affiliates, reported a 3.3% passive beneficial ownership stake in Teladoc Health, Inc., totaling 5,795,178 shares.

The Vanguard Group has reported a beneficial ownership of 11.98% of Teladoc Health Inc.'s common stock, holding over 21 million shares as a passive investment.

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly disclosed a beneficial ownership of 5.0% in Teladoc Health, Inc., totaling 8,826,350 shares.

Point72 Asset Management, along with its affiliates and Steven A. Cohen, has filed an amended Schedule 13G disclosing a 4.3% beneficial ownership stake in Teladoc Health, Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.8% beneficial ownership stake in Teladoc Health Inc. as of March 31, 2025.

Point72 Asset Management, L.P., along with its affiliates and founder Steven A. Cohen, has disclosed a passive beneficial ownership of 7.2% in Teladoc Health, Inc. common stock as of December 31, 2024.

ARK Investment Management LLC has reported a complete divestment of its beneficial ownership in Teladoc Health, Inc., reducing its stake to 0.0% as of September 30, 2024.